Gland Pharma Limited (NSE:GLAND)

Gland Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	243,625	303,932	208,882	537,705	405,432	-
Market Cap Growth	-7.51%	45.50%	-61.15%	32.63%	-	-
Enterprise Value	218,691	286,055	175,977	508,469	390,204	-
Last Close Price	1478.70	1826.40	1255.30	3239.23	2452.99	-
PE Ratio	34.58	39.35	26.74	44.38	40.67	-
Forward PE	26.18	29.26	17.57	35.96	34.98	-
PS Ratio	4.25	5.37	5.76	12.22	11.71	-
PB Ratio	2.77	3.48	2.63	7.51	6.87	-
P/TBV Ratio	2.89	3.63	2.63	7.53	6.87	-
P/FCF Ratio	-	50.08	146.03	192.42	107.78	-
P/OCF Ratio	-	30.49	57.39	68.00	67.02	-
PEG Ratio	1.52	1.58	1.59	1.44	1.53	-
EV/Sales Ratio	3.82	5.05	4.86	11.55	11.27	-
EV/EBITDA Ratio	15.80	21.77	17.07	33.67	29.97	-
EV/EBIT Ratio	24.16	28.94	19.90	36.32	32.42	-
EV/FCF Ratio	-	47.14	123.03	181.96	103.74	-
Debt / Equity Ratio	0.04	0.04	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.24	0.28	0.00	0.00	0.00	0.01
Debt / FCF Ratio	-	0.61	0.03	0.02	0.01	0.01
Asset Turnover	-	0.58	0.44	0.61	0.65	0.69
Inventory Turnover	-	1.40	1.16	1.79	1.56	1.44
Quick Ratio	-	2.61	6.58	7.80	7.31	5.50
Current Ratio	-	4.04	9.46	10.06	10.00	7.93
Return on Equity (ROE)	-	9.26%	10.33%	18.55%	20.88%	23.75%
Return on Assets (ROA)	-	6.36%	6.65%	12.21%	14.22%	14.14%
Return on Capital (ROIC)	6.37%	7.24%	7.31%	13.39%	15.73%	16.50%
Return on Capital Employed (ROCE)	-	10.70%	11.00%	19.30%	20.10%	23.10%
Earnings Yield	2.89%	2.54%	3.74%	2.25%	2.46%	-
FCF Yield	-	2.00%	0.69%	0.52%	0.93%	-
Dividend Yield	1.38%	1.09%	-	-	-	-
Buyback Yield / Dilution	-0.01%	-0.03%	-0.09%	-3.96%	-2.15%	-
Total Shareholder Return	1.37%	1.06%	-0.09%	-3.96%	-2.15%	-

Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.